U.S. markets open in 4 hours 33 minutes
  • S&P Futures

    4,161.75
    -14.00 (-0.34%)
     
  • Dow Futures

    34,123.00
    -83.00 (-0.24%)
     
  • Nasdaq Futures

    12,733.50
    -43.25 (-0.34%)
     
  • Russell 2000 Futures

    1,969.30
    -10.00 (-0.51%)
     
  • Crude Oil

    78.29
    +1.15 (+1.49%)
     
  • Gold

    1,897.90
    +13.10 (+0.70%)
     
  • Silver

    22.52
    +0.34 (+1.55%)
     
  • EUR/USD

    1.0757
    +0.0027 (+0.25%)
     
  • 10-Yr Bond

    3.6740
    0.0000 (0.00%)
     
  • Vix

    18.89
    -0.54 (-2.78%)
     
  • GBP/USD

    1.2107
    +0.0055 (+0.46%)
     
  • USD/JPY

    130.6700
    -0.4020 (-0.31%)
     
  • BTC-USD

    23,195.02
    +200.69 (+0.87%)
     
  • CMC Crypto 200

    534.72
    +8.77 (+1.67%)
     
  • FTSE 100

    7,915.82
    +51.11 (+0.65%)
     
  • Nikkei 225

    27,606.46
    -79.01 (-0.29%)
     

Is Weakness In Molina Healthcare, Inc. (NYSE:MOH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Molina Healthcare (NYSE:MOH) has had a rough month with its share price down 5.9%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. Particularly, we will be paying attention to Molina Healthcare's ROE today.

Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.

Check out our latest analysis for Molina Healthcare

How Do You Calculate Return On Equity?

ROE can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Molina Healthcare is:

28% = US$839m ÷ US$3.0b (Based on the trailing twelve months to September 2022).

The 'return' is the income the business earned over the last year. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.28 in profit.

Why Is ROE Important For Earnings Growth?

So far, we've learned that ROE is a measure of a company's profitability. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.

Molina Healthcare's Earnings Growth And 28% ROE

First thing first, we like that Molina Healthcare has an impressive ROE. Secondly, even when compared to the industry average of 13% the company's ROE is quite impressive. So, the substantial 31% net income growth seen by Molina Healthcare over the past five years isn't overly surprising.

Next, on comparing with the industry net income growth, we found that Molina Healthcare's growth is quite high when compared to the industry average growth of 16% in the same period, which is great to see.

past-earnings-growth
past-earnings-growth

The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. Is Molina Healthcare fairly valued compared to other companies? These 3 valuation measures might help you decide.

Is Molina Healthcare Making Efficient Use Of Its Profits?

Molina Healthcare doesn't pay any dividend to its shareholders, meaning that the company has been reinvesting all of its profits into the business. This is likely what's driving the high earnings growth number discussed above.

Summary

In total, we are pretty happy with Molina Healthcare's performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see substantial growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here